HCA Healthcare, Inc. (HCA) Stock

About HCA Healthcare, Inc.

HCA Healthcare, Inc. is led by CEO Samuel N. Hazen, employs 320,000 people, headquartered in Nashville, US, publicly traded since 2011.

HCA Healthcare, Inc. (HCA) stock trades at $469.03 with a market capitalization of $101.55B. The stock is valued at a price-to-earnings (P/E) ratio of 15.41, a negative price-to-book of -15.65, reflecting negative shareholders' equity, price-to-sales of 1.28. Over the past 52 weeks the stock has ranged between $353.99 and $556.52, and currently trades 15.7% below its 52-week high. It pays a dividend yielding 0.67%.

On profitability, HCA Healthcare, Inc. generates a return on equity (ROE) of -112.87% (not meaningful, as shareholders' equity is negative), return on capital employed of 29.17%, an operating margin of 15.83%, a net profit margin of 8.77%.

In its most recent fiscal year, HCA Healthcare, Inc. reported annual revenue of $75.6B, net profit of $6.8B. Over the last 5 fiscal years, revenue grew at an average annual rate of 8.0%, and net profit grew at an average annual rate of 12.6%. Over that span net profit grew faster than revenue, so net margin widened.

The balance sheet shows a debt-to-equity ratio of -7.42 (negative because shareholders' equity is negative), a current ratio of 0.83, total assets of $60.7B, $1.0B in cash and equivalents.

HCA has an average daily trading volume of 1,440,453 shares, a beta of 1.11.

HCA Healthcare, Inc. by the numbers, 2016–2025

Between 2016 and 2025 HCA Healthcare, Inc. reported revenue of $41.5B rising to $75.6B, a change of +82.2% across 10 years. Compounded, revenue has grown 8.0% a year over five years, 7.9% over three, 7.1% over the last twelve months. Net profit rose to $6.8B.

Operating margin went from 14.9% in 2016 to 15.8% in 2025, essentially unchanged. The most recent net margin is 8.77%. On a trailing twelve-month basis to Jun '26, revenue is $78.0B and net profit $6.8B.

Borrowings rose from $31.4B to $50.2B, cash from operations was $12.6B in the latest year, positive in 10 of the last 10.

Return on equity has averaged -317.6% over five years, and was -112.6% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

HCA Healthcare, Inc. (HCA) — frequently asked questions